Basilar artery stroke trial for later treatment
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests if endovascular therapy (a procedure to remove a clot) can help people who have had a stroke in the back part of the brain (basilar artery) and can be treated within 72 hours, even if they are not eligible for clot-dissolving medicine. The treatment may improve recovery compared to standard care alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stroke in the back of the brain (basilar artery or both vertebral arteries), confirmed by a brain scan.
- You can start treatment within 24 to 72 hours from the time your stroke symptoms began.
- You are between 18 and 80 years old.
- You have a moderate to severe stroke (NIHSS score of 6 or higher) at the start of the trial.
- You were able to do your usual daily activities without help before the stroke (mRS score 0 or 1).
- You are not able to receive or did not respond to clot-dissolving medicine (IV thrombolysis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure to remove a clot in a major artery in the back of the brain (basilar artery) in patients who have had a large stroke there within the past 24 hours. It aims to see if opening the blocked artery can improve recovery.
This trial tests whether a minimally invasive procedure to remove a blood clot from the basilar artery in the back of the brain is safe and effective for people with mild to moderate stroke symptoms. It may be an option if you have a confirmed blockage and can be treated within 24 hours of stroke onset.
This trial tests if a clot-busting drug called Tenecteplase helps people with a severe type of stroke in the back of the brain (basilar artery occlusion) when given 4.5 to 24 hours after symptoms start. Patients will then be moved to a hospital that can remove the clot. The goal is to see if the drug improves recovery.
This trial tests endovascular therapy (a procedure to remove a clot through a tube in an artery) versus medical management for people with a severe stroke due to a blockage in the back part of the brain (basilar artery) and a large area of brain damage. The goal is to see if the procedure improves outcomes compared to medication alone.
This trial tests a procedure to open a blocked artery in the back of the brain (basilar artery) for people who had a mild stroke that later got worse. If you are eligible, you may receive this treatment up to 24 hours after your symptoms worsen.
This trial tests a procedure to remove a blood clot from the main artery at the back of the brain (basilar artery) in people who have a large stroke. The goal is to see if this treatment can improve recovery even when the stroke damage is bigger than usual.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.